← Leaderboards
Joal D Beane
Ohio State University
$198,219
Attributed
$396,437
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $218.5K · FY2022–23$250K$187.5K$125K$62.5K$0
'22
'23
Funding mix
By agency
NIH$396,437 · 1
By mechanism
R21$396,437 · 1
Top collaborators
- Aleksander Skardal2 shared
Most similar at Ohio State University
Same institution · by research overlap
- Patrick Lee Green$10,720,230
- Michael A Caligiuri$65,062,344
- Fernanda Novais$1,680,973
- Emily Ann Hemann$1,861,670
- Lapo Alinari$4,506,413
Others in their field
Other Rising Stars on “Cytolysis”
- John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc.$6,183,017
- Nam-Joon Cho · Stanford University$2,909,919
- Ze Zheng · Medical College Of Wisconsin$2,576,571
- Heather Leigh Herd Gustafson · Seattle Children'S Hospital$2,399,099
- Todd McFarland · Cerulean Scientific Inc.$2,089,866
- Jayhun Lee · University Of Texas Hlth Sci Ctr Houston$2,064,827
Research focus
CytolysisAdaptive Immune ResponseAdvanced Malignant NeoplasmAdoptive Cell TransfersAdoptive TransferAutologousAutologous Tumor CellBackAntigen-Presenting CellsBlood CellsAntigensCancer CellCd8b1 GeneCell ProliferationCellsCell SurvivalCell TherapyChimeric Antigen Receptor T CellsBiomedical EngineeringClinical ApplicationCoculture TechniquesComplementarity-Determining Region 3ComplexCytometry
Grant awards (2)
Ex vivo generation of tumor-reactive T cells for adoptive cell transfer using an immune enhanced, patient derived tumor organoid-on-a-chip (iTOC)$177,924
R21 · FY2023 · CA
Ex vivo generation of tumor-reactive T cells for adoptive cell transfer using an immune enhanced, patient derived tumor organoid-on-a-chip (iTOC)$218,513
R21 · FY2022 · CA